Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992926priorityCriticalpatent/ECSP992926A/en
Publication of ECSP992926ApublicationCriticalpatent/ECSP992926A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a dihidropirimidinas de fórmula general (I) (gráfico), asi como al uso de dihidropirimidinas como medicamento para el tratamiento y profilaxis de la hepatitis B. La invención se refiere, además, a un procedimiento para la producción de medicamentos que contienen las mencionadas dihidropirimidinas.The invention relates to dihydropyrimidines of general formula (I) (graph), as well as to the use of dihydropyrimidines as a medicament for the treatment and prophylaxis of hepatitis B. The invention further relates to a process for the production of medicaments which contain the mentioned dihydropyrimidines.
ECSP9929261999-04-161999-04-16
USE OF DIHYDROPYRIMIDINES AS MEDICATION AND NEW SUBSTANCES (CASE READ 32791)
ECSP992926A
(en)
HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
compounds, process for their manufacture, pharmaceutical compositions comprising them, method for the treatment and / or prophylaxis of diseases that are associated with the glucagon receptor and their use
compound, pharmaceutical composition, use of a compound, method of treating a human suffering from a hyperproliferative disease such as cancer, and process for the preparation of a compound
COMPOSITE DERIVED FROM CYCLOPENTAPIRIDIN-KETONE, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE IN THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO TREAT A DISEASE